medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 9, 2024
Abstract
The
development
of
Artificial
Intelligence
(AI)
in
the
healthcare
sector
is
generating
a
great
impact.
However,
one
primary
challenges
for
implementation
this
technology
access
to
high-quality
data
due
issues
collection
and
regulatory
constraints,
which
synthetic
an
emerging
alternative.
This
Scoping
review
analyses
reviews
from
past
10
years
three
different
databases
(i.e.,
PubMed,
Scopus,
Web
Science)
identify
domains
where
are
currently
generated,
motivations
behind
their
creation,
future
uses,
limitations,
types
data.
A
total
13
main
were
identified,
with
Oncology,
Neurology,
Cardiology
being
most
frequently
mentioned.
Five
principal
uses
also
identified.
Furthermore,
it
was
found
that
predominant
type
generated
unstructured,
particularly
images.
Finally,
several
work
directions
suggested,
including
exploring
new
less
commonly
used
(e.g.,
video
text),
developing
evaluation
benchmark
standard
generative
models
specific
domains.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(8), P. 1758 - 1758
Published: Aug. 5, 2024
Uveal
melanoma
(UM)
is
the
most
common
intraocular
malignancy
in
adults.
Recent
advances
highlight
role
of
tumor-derived
extracellular
vesicles
(TEV)
and
circulating
hybrid
cells
(CHC)
UM
tumorigenesis.
Bridged
with
liquid
biopsies,
a
novel
technology
that
has
shown
incredible
performance
detecting
cancer
or
products
derived
from
tumors
bodily
fluids,
it
can
significantly
impact
disease
management
outcome.
The
aim
this
comprehensive
literature
review
to
provide
summary
current
knowledge
ongoing
posterior
pathophysiology,
diagnosis,
treatment.
first
section
manuscript
discusses
complex
intricate
TEVs
CHCs.
second
part
delves
into
epidemiology,
etiology
risk
factors,
clinical
presentation,
prognosis
UM.
Third,
diagnostic
methods,
ensued
by
tools
for
early
detection
UM,
such
as
biopsies
artificial
intelligence-based
technologies,
are
paramount
importance
review.
fundamental
principles,
limits,
challenges
associated
these
tools,
well
their
potential
tracker
progression,
discussed.
Finally,
treatment
modalities
provided,
followed
an
overview
preclinical
research
studies
further
insights
on
biomolecular
pathway
alterations
therapeutic
targets
This
thus
important
resource
all
healthcare
professionals,
clinicians,
researchers
working
field
ocular
oncology.
IP International Journal of Ocular Oncology and Oculoplasty,
Journal Year:
2025,
Volume and Issue:
10(4), P. 196 - 207
Published: Jan. 14, 2025
In
the
domains
of
ocular
oncology
and
oculoplasty,
machine
learning
(ML)
has
become
a
game-changing
technology,
providing
previously
unheard-of
levels
precision
in
diagnosis,
treatment
planning,
outcome
prediction.
Using
imaging
modalities,
genomic
data,
clinical
characteristics,
this
chapter
investigates
integration
algorithms
detection
tumours,
including
retinoblastoma
uveal
melanoma.
Through
predictive
modelling
real-time
decision-making,
it
also
emphasises
how
ML
might
improve
surgical
outcomes
orbital
reconstruction
eyelid
correction.
Automated
examination
fundus
photographs,
histological
slides,
3D
been
made
possible
by
methods
like
deep
natural
language
processing,
which
have
improved
individualised
therapeutic
approaches
decreased
diagnostic
errors.
Additionally,
use
augmented
reality
robotics
surgery
is
significant
development
oculoplasty.
Notwithstanding
its
potential,
issues
data
heterogeneity,
algorithm
interpretability,
ethical
considerations
are
roadblocks
that
need
to
be
addressed.
This
explores
cutting-edge
developments,
real-world
uses,
potential
future
paths,
offering
researchers
doctors
thorough
resource.
Dipali
Vikas
Mane,
Associate
Professor,
Shriram
Shikshan
Sanstha’s
College
Pharmacy,
Paniv-413113
Ophthalmic Genetics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 6
Published: Jan. 20, 2025
Retinoblastoma
is
diagnosed
and
treated
without
biopsy
based
solely
on
appearance
(with
the
indirect
ophthalmoscope
imaging).
More
than
20
benign
ophthalmic
disorders
resemble
retinoblastoma
errors
in
diagnosis
continue
to
be
made
worldwide.
A
better
noninvasive
method
for
distinguishing
from
pseudo
needed.
RetCam
imaging
of
largest
center
U.S.
(Memorial
Sloan
Kettering
Cancer
Center,
New
York,
NY)
were
used
this
study.
We
several
neural
networks
(ResNet-18,
ResNet-34,
ResNet-50,
ResNet-101,
ResNet-152,
a
Vision
Image
Transformer,
or
VIT),
using
80%
images
training,
10%
validation,
testing.
Two
thousand
eight
hundred
eighty-two
patients
with
at
diagnosis,
1,970
804
normal
pediatric
fundus
included.
The
highest
sensitivity
(98.6%)
was
obtained
ResNet-101
model,
as
accuracy
F1
scores
97.3%
97.7%.
specificity
(97.0%)
precision
attained
ResNet-152
model.
Our
machine
learning
algorithm
successfully
distinguished
high
if
implemented
worldwide
will
prevent
hundreds
eyes
incorrectly
being
surgically
removed
yearly.
Acta Ophthalmologica,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 31, 2025
To
report
how
the
evolving
role
of
optometrists
in
primary
eye
care
and
advances
ophthalmic
imaging
have
affected
diagnosis
management
posterior
uveal
melanoma
(UM).
Retrospective,
single-centre
cohort
study
patients
diagnosed
with
UM
from
1993
to
2022
Bergen,
Norway.
Four
hundred
nine
were
included,
comparisons
made
between
those
2007
2008
2022.
The
median
tumour
diameter
decreased
13.3
11.3
mm
(p
=
0.002),
thickness
6.9
4.5
<
0.001).
distance
border
optic
disc
foveola
increased
3.5
0.011),
3.0
4.0
0.001),
respectively.
Two
sixty-two
(64%)
experienced
symptoms
associated
UM,
a
duration
152.5
81
days
first
second
half
period,
respectively
best
corrected
visual
acuity
at
improved
0.5
logMAR
(Snellen
equivalent,
6/19)
0.2
6/9.5)
period
proportion
asymptomatic
was
23.5%
41.9%
UMs
incidentally
detected
by
3.0%
18.1%
0.009),
fundus
photography
1.5%
temporal
changes
patient
characteristics
suggest
that
are
now
being
an
earlier
stage.
This
may
part
be
attributed
introduction
widefield
cameras
opportunistic
screening
patients.
Cells,
Journal Year:
2024,
Volume and Issue:
13(12), P. 1023 - 1023
Published: June 12, 2024
Uveal
melanoma
(UM),
a
distinct
subtype
of
melanoma,
presents
unique
challenges
in
its
clinical
management
due
to
complex
molecular
landscape
and
tendency
for
liver
metastasis.
This
review
highlights
recent
advancements
understanding
the
pathogenesis,
genetic
alterations,
immune
microenvironment
UM,
with
focus
on
pivotal
genes,
such
as
GNAQ/11,
BAP1,
CYSLTR2,
delves
into
distinctive
chromosomal
classifications
emphasizing
role
mutations
rearrangements
disease
progression
metastatic
risk.
Novel
diagnostic
biomarkers,
including
circulating
tumor
cells,
DNA
extracellular
vesicles,
are
discussed,
offering
potential
non-invasive
approaches
early
detection
monitoring.
It
also
explores
emerging
prognostic
markers
their
implications
patient
stratification
personalized
treatment
strategies.
Therapeutic
approaches,
histone
deacetylase
inhibitors,
MAPK
pathway
trends
concepts
like
CAR
T-cell
therapy,
evaluated
efficacy
UM
treatment.
identifies
research,
limited
options
need
improved
tools,
suggests
future
directions,
discovery
novel
therapeutic
targets,
immunotherapeutic
strategies,
advanced
drug
delivery
systems.
The
concludes
by
importance
continued
research
innovation
addressing
improve
outcomes
develop
more
effective
Cancer Cell International,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Oct. 30, 2024
Uveal
melanoma
(UM)
is
adults'
most
common
primary
intraocular
malignant
tumor.
It
has
been
observed
that
40%
of
patients
experience
distant
metastasis
during
subsequent
treatment.
While
there
exist
multigene
models
developed
using
machine
learning
methods
to
assess
and
prognosis,
the
immune
microenvironment's
specific
mechanisms
influencing
tumor
microenvironment
have
not
clarified.
Single-cell
transcriptome
sequencing
can
accurately
identify
different
types
cells
in
a
tissue
for
precise
analysis.
This
study
aims
develop
model
with
fewer
genes
evaluate
risk
UM
provide
theoretical
basis
immunotherapy.